Literature DB >> 19326165

Rosai-Dorfman disease with factor XII deficiency.

Esen Kasapoglu Gunal1, Sevil Kamali, Mehmet Fatih Akdogan, Arif Oguz Cimen, Lale Ocal, Mehmet Agan, Ahmet Gul, Murat Inanc, Meral Konice, Orhan Aral.   

Abstract

A 17-year-old female patient presented with chronic symmetrical oligoarthritis of both knees and ankles, xerostomia, xerophthalmia, multiple bilateral lymphadenopathies in the cervical region, and bilateral parotid enlargement with the histological finding of chronic sialoadenitis. She had been already given methotrexate, chloroquine, and corticosteroids with the diagnosis of rheumatoid arthritis (RA) before referral to our outpatient clinic. Because her complaints and the lumps did not remit and she could be classified as neither RA nor primary Sjögren's syndrome (SS) according to 1987 ACR RA criteria or European preliminary criteria for SS, lymph node biopsy was repeated and revealed the diagnosis of Rosai-Dorfman disease (RDD) with the histological findings of histiocytes, phagocyting lymphocytes in enlarged sinuses, and mature plasma cells infiltrating the pulpa. All the medications were stopped after the pathological diagnosis of RDD and consulting with the Division of Hematology. She was reevaluated with magnetic resonance imaging, which showed dense infiltrative areas around knee and ankle joints, and computed tomography that showed a soft tissue mass surrounding the descending aorta and upper part of the abdominal aorta. Activated partial thromboplastin time was found to be prolonged in prebiopsy examinations, and factor XII deficiency was detected after detailed hematological evaluation. The symptoms of joint involvement were relieved with nonsteroidal antiinflammatory drugs. She has been followed-up without medication without obvious clinical or laboratory change. We herein report a patient with RDD mimicking RA and SS. We consider that RDD should be kept in mind especially in patients with resistant symptoms to conventional therapies, younger disease onset, and predominant parotid and lymph node enlargement.

Entities:  

Mesh:

Year:  2009        PMID: 19326165     DOI: 10.1007/s10067-009-1127-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

Review 1.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity.

Authors:  E Foucar; J Rosai; R Dorfman
Journal:  Semin Diagn Pathol       Date:  1990-02       Impact factor: 3.464

Review 2.  The treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

Authors:  D M Komp
Journal:  Semin Diagn Pathol       Date:  1990-02       Impact factor: 3.464

3.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Authors:  J Rosai; R F Dorfman
Journal:  Arch Pathol       Date:  1969-01

4.  ["Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab].

Authors:  F Petschner; U A Walker; A Schmitt-Gräff; M Uhl; H H Peter
Journal:  Dtsch Med Wochenschr       Date:  2001-09-14       Impact factor: 0.628

Review 5.  The contact system.

Authors:  Craig S Kitchens
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

6.  Sinus histiocytosis with massive lymphadenopathy: a spectrum of disease associated with immune dysfunction.

Authors:  D L Maennle; H L Grierson; D G Gnarra; D D Weisenburger
Journal:  Pediatr Pathol       Date:  1991 May-Jun

7.  The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.

Authors:  W M Halbmayer; A Haushofer; R Schön; C Mannhalter; E Strohmer; K Baumgarten; M Fischer
Journal:  Thromb Haemost       Date:  1994-01       Impact factor: 5.249

8.  Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme.

Authors:  F Bernardi; G Marchetti; P Patracchini; L del Senno; M Tripodi; A Fantoni; S Bartolai; F Vannini; L Felloni; L Rossi
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

Review 9.  Inherited bleeding disorders.

Authors:  V S Blanchette; C Sparling; C Turner
Journal:  Baillieres Clin Haematol       Date:  1991-04

10.  Sinus histiocytosis with massive lymphadenopathy. An analysis of 14 deaths occurring in a patient registry.

Authors:  E Foucar; J Rosai; R F Dorfman
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

  10 in total
  1 in total

Review 1.  Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature.

Authors:  Francesco di Dio; Ilaria Mariotti; Elena Coccolini; Patrizia Bruzzi; Barbara Predieri; Lorenzo Iughetti
Journal:  BMC Pediatr       Date:  2016-05-03       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.